ApS NORA BIO: Financial statements 2024
CVR: 15206381
Source: annual report 2024, Danish Business Authority
01/01/2024 – 31/12/2024
ApS NORA BIO (CVR 15206381) has filed annual accounts for 2024. In 2024, the company reported a gross profit of DKK 2,637,950 and a net result of DKK 2,569,096 compared with DKK 2,287,660 the year before. That is a decrease of 13% compared with the year before. Equity in the 2024 report amounted to DKK 30,410,325. The solvency ratio was 58.9%.
- Gross Profit
- DKK 2,637,950
- Profit/Loss
- DKK 2,569,096
- Equity
- DKK 30,410,325
- Total Assets
- DKK 51,597,020
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2024 | - | 2.6 mio. | 2.6 mio. | 30.4 mio. | - |
| 2023 | - | 3 mio. | 2.3 mio. | 27.8 mio. | - |
| 2022 | - | 2.8 mio. | 11.6 mio. | 25.6 mio. | - |
| 2021 | - | 2.7 mio. | 2.3 mio. | 14 mio. | - |
| 2020 | 3.4 mio. | 2.6 mio. | 2.3 mio. | 21.7 mio. | - |
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2024
ApS NORA BIO has published its annual report for 2023. Gross profit came to DKK 3,032,215, and the net result was DKK 2,287,660.
About ApS NORA BIO
ApS NORA BIO is a Danish company of the type Anpartsselskab based in Hellerup, founded in 1991. The company is registered under the industry Udlejning af erhvervsejendomme. The company was previously named COLUMBUS FINANS II ApS and ApS KBIL 38 NR. 1514. The management consists of David Choleva. The company is owned by Adyn Ejendomme ApS. According to the 2025 annual report, the company had an average of 1 employee. In 2025, the company reported a gross profit of DKK 2,897,201 and a net result of DKK 1,558,547 compared with DKK 2,569,096 the year before. Equity in the 2025 report amounted to DKK 31,968,872.